- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06757608
Postprandial Responses to Fish Intake (PREFish)
December 26, 2024 updated by: Jarlei Fiamoncini, University of Sao Paulo
Postprandial Responses to Fish Intake: in Vivo and in Vitro Study
Fish consumption has been increasing in recent decades due to consumer interest in the positive health effects of regular food intake, among other factors.
Previous studies have described significant results on the acute consumption of fish products, favoring the reduction of triglycerides, total cholesterol, low-density lipoprotein, reduced insulin secretion, and increased plasma concentration of high-density lipoprotein during the postprandial period.
Despite this scenario, studies investigating acute metabolic responses, such as postprandial physiological phenomena after consumption of the main fish species ingested by Brazilians, are still scarce.
Thus, investigations of the acute effects of fish intake on postprandial metabolism may reveal new beneficial effects associated with this food group.
The present proposal aims to compare the acute effects of the ingestion of two sources of fish and bovine protein on postprandial metabolism through the capillary blood sample collected within 5 hours after the ingestion of test meals, investigating hormones and inflammatory mediators and quantifying triglycerides, total cholesterol and non-esterified fatty acids and blood glucose, in addition to evaluating sensory aspects and satiety between different meals.
It is expected to generate new data on postprandial physiology and investigate possible effects of fish ingestion that can contribute to public health management and healthy eating patterns.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 05508-000
- University of Sao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy adults between 18 and 35 years and with a body mass index between 20 and 29 kg/m2.
Exclusion Criteria:
- Individuals with a vegetarian/vegan diet, a history of fish allergy, aversion to fish, used supplementation with n-3 polyunsaturated fatty acids or probiotics, who have a diagnosis of pregnancy, dyslipidemia, diabetes, inflammatory bowel disease, liver disease, who have undergone surgeries that alter the anatomy of the digestive tract (bariatric surgery or cholecystectomy, for example) and use of antimicrobial therapy in the 3 months before the study will not be allowed to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Tambaqui meat
Tambaqui (Colossoma macropomum) meat intake, 7g per BMI unit
|
30 healthy adults (15 male and 15 female) consumed sardines (Opisthonema oglinum, marine fish), tambaqui (Colossoma macropomum, freshwater culture), and beef (Bos taurus).
The meal consisted only of meat, with 7g per BMI unit.
The postprandial response was observed for 5 hours, after an overnight fast.
|
|
Active Comparator: Sardine meat
Sardine (Opisthonema oglinum) meat intake, 7g per BMI unit
|
30 healthy adults (15 male and 15 female) consumed sardines (Opisthonema oglinum, marine fish), tambaqui (Colossoma macropomum, freshwater culture), and beef (Bos taurus).
The meal consisted only of meat, with 7g per BMI unit.
The postprandial response was observed for 5 hours, after an overnight fast.
|
|
Active Comparator: Beef
Beef (Bos taurus) meat intake, 7g per BMI unit
|
30 healthy adults (15 male and 15 female) consumed sardines (Opisthonema oglinum, marine fish), tambaqui (Colossoma macropomum, freshwater culture), and beef (Bos taurus).
The meal consisted only of meat, with 7g per BMI unit.
The postprandial response was observed for 5 hours, after an overnight fast.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma markers of intermediate metabolism and inflammation
Time Frame: 3 weeks
|
Capillary blood samples (approximately 500 µL) were collected after a 12-hour fasting and in different time points within a 5-hours interval after food intake to assess plasma metabolic and inflammatory markers (cytokines), aiming at identifying their response to the food intake.
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urine metabolome
Time Frame: 3 weeks
|
Urine samples were collected after a 12-hours fasting and during the postprandial period (all urine produced during the first 5 hours following food intake) to assess changes in urinary metabolome induced by the intake of the tested meal.
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2024
Primary Completion (Estimated)
September 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
December 26, 2024
First Submitted That Met QC Criteria
December 26, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 26, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 69418723.6.0000.0067
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-prandial Glycaemic Response
-
BioglaneCompletedReduction of Post-prandial Glycaemic ResponseUnited Kingdom
-
St. Boniface HospitalUniversity of Manitoba; Agriculture and Agri-Food Canada; Saskatchewan Pulse...Completed
-
St. Boniface HospitalUniversity of Manitoba; Agriculture and Agri-Food CanadaActive, not recruitingSatiety | Post-prandial Glycaemic ResponseCanada
-
St. Boniface HospitalUniversity of Manitoba; Agriculture and Agri-Food CanadaActive, not recruitingSatiety | Post-prandial Glycaemic ResponseCanada
-
University of Alabama at BirminghamMcCormick Science InstituteRecruitingPost-prandial Glucose ResponseUnited States
-
St. Boniface HospitalAgriculture and Agri-Food CanadaActive, not recruiting
-
St. Boniface HospitalAgriculture and Agri-Food CanadaWithdrawn
-
Mondelēz International, Inc.Reading Scientific Services Ltd.CompletedGlycaemic Index | Glycaemic Response
-
University of BathCompletedGlycaemic Index | Glycaemic Response MeasurementsUnited Kingdom
-
BioglaneUniversity Rovira i Virgili; National Research Council, Spain; Technological...CompletedInsulinemic Response | Glycaemic ResponseSpain
Clinical Trials on Assessment of postprandial metabolism after intake of different meat
-
University Hospital, GhentUniversity GhentCompletedType 1 Diabetes MellitusBelgium
-
West German Center of Diabetes and HealthBionorica SECompletedPostprandial Glucose Response | Glycaemic Index | Continous Glucose MeasurementGermany
-
Leiden University Medical CenterNot yet recruitingRecurrent Pregnancy Loss
-
University Hospital, Basel, SwitzerlandRicola Group AG SchweizCompleted
-
University of Southern DenmarkUniversity of Aarhus; Danish Cancer Society; Odense Patient Data Explorative... and other collaboratorsActive, not recruitingAutoimmune Diseases | Inflammatory Bowel Diseases | Spondylarthropathies | Multiple Sclerosis (MS) | Crohn Disease (CD) | Ulcerative Colitis (UC) | Arthritis, Rheumatoid (RA) | Arthritis, Psoriatic (PsA) | Psoriasis (PsO)Denmark
-
Medical University of WarsawNot yet recruitingGastric Emptying | Healthy Volunteer Study | Preoperative Risk AssessmentPoland
-
University of FoggiaActive, not recruiting
-
University of MichiganCompletedDental Pulp DiseasesUnited States
-
University of Southern DenmarkOdense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaboratorsCompletedAutoimmune Diseases | Inflammatory Bowel Diseases | Uveitis | Psoriasis | Spondylarthropathies | Crohn Disease (CD) | Arthritis, Rheumatoid (RA) | Arthritis, Psoriatic (PsA) | Hidradenitis Suppurativa (HS) | Colitis, Ulcerative (UC)Denmark
-
Yeditepe UniversityCompletedCybersicknessTurkey